Literature DB >> 416908

Inhibition of polycyclic aromatic hydrocarbon-induced neoplasia by naturally occurring indoles.

L W Wattenberg, W D Loub.   

Abstract

Indole-3-carbinol, 3,3'-diindolylmethane, and indole-3-acetonitrile, three indoles occurring in edible cruciferous vegetables, have been studied for their effects on 7,12-dimethylbenz(a)anthracene-induced mammary tumor formation in female Sprague-Dawley rats and on benzo(a)pyrene-induced neoplasia of the forestomach in female ICR/Ha mice. When given by p.o. intubation 20 hr prior to 7,12-dimethylbenz(a)anthracene administration, indole-3-carbinol and 3,3'-diindolylmethane had an inhibitory effect on mammary tumor formation, but indole-3-acetonitrile was inactive. Indole-3-carbinol when added to the diet for 8 days prior to challenge with 7,12-dimethylbenz(a)anthracene inhibited mammary tumor formation, whereas indole-3-acetonitrile did not. Dietary administration of all three indoles inhibited benzo(a)pyrene-induced neoplasia of the forestomach in ICR/Ha mice. The identification of dietary constituents that can inhibit chemical carcinogens ultimately may be of value in understanding the balance of factors that determines the neoplastic response to these cancer-producing agents in the environment.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 416908

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  44 in total

1.  Nutrients and pancreatic cancer: a population-based case-control study.

Authors:  G W Olsen; J S Mandel; R W Gibson; L W Wattenberg; L M Schuman
Journal:  Cancer Causes Control       Date:  1991-09       Impact factor: 2.506

2.  Dietary factors in aetiology and prevention of cancer in man.

Authors:  A Kwiatkowski
Journal:  Environ Geochem Health       Date:  1990-09       Impact factor: 4.609

3.  Indole-3-carbinol suppresses NF-kappaB and IkappaBalpha kinase activation, causing inhibition of expression of NF-kappaB-regulated antiapoptotic and metastatic gene products and enhancement of apoptosis in myeloid and leukemia cells.

Authors:  Yasunari Takada; Michael Andreeff; Bharat B Aggarwal
Journal:  Blood       Date:  2005-04-05       Impact factor: 22.113

4.  Malignant transformation of mammary epithelial cells by ectopic overexpression of the aryl hydrocarbon receptor.

Authors:  J Brooks; S E Eltom
Journal:  Curr Cancer Drug Targets       Date:  2011-06       Impact factor: 3.428

5.  Indole-3-carbinol inhibits MDA-MB-231 breast cancer cell motility and induces stress fibers and focal adhesion formation by activation of Rho kinase activity.

Authors:  Christine T Brew; Ida Aronchik; Karena Kosco; Jasmine McCammon; Leonard F Bjeldanes; Gary L Firestone
Journal:  Int J Cancer       Date:  2009-05-15       Impact factor: 7.396

Review 6.  Influence of diet and nutritional status on drug metabolism.

Authors:  I Walter-Sack; U Klotz
Journal:  Clin Pharmacokinet       Date:  1996-07       Impact factor: 6.447

7.  Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms and gastric cancer risk: a prospective study of men in Shanghai, China.

Authors:  Kristin A Moy; Jian-Min Yuan; Fung-Lung Chung; Xue-Li Wang; David Van Den Berg; Renwei Wang; Yu-Tang Gao; Mimi C Yu
Journal:  Int J Cancer       Date:  2009-12-01       Impact factor: 7.396

Review 8.  Vegetables, fruit, and cancer. II. Mechanisms.

Authors:  K A Steinmetz; J D Potter
Journal:  Cancer Causes Control       Date:  1991-11       Impact factor: 2.506

9.  Anti-adult T-cell leukemia/lymphoma effects of indole-3-carbinol.

Authors:  Yoshiaki Machijima; Chie Ishikawa; Shigeki Sawada; Taeko Okudaira; Jun-nosuke Uchihara; Yuetsu Tanaka; Naoya Taira; Naoki Mori
Journal:  Retrovirology       Date:  2009-01-16       Impact factor: 4.602

10.  Induction of G1 and G2/M cell cycle arrests by the dietary compound 3,3'-diindolylmethane in HT-29 human colon cancer cells.

Authors:  Hyun Ju Choi; Do Young Lim; Jung Han Yoon Park
Journal:  BMC Gastroenterol       Date:  2009-05-29       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.